Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
In a multi-institutional study published in ScientificResearchers revealed that testing urine-based tumors DNA (UTDNA) can help to estimate which bladder cancer patients are at greater risk for recurrence after treatment. This study analyzed UTDNA from patients in the Swog S1605 test, which was treated with ATEZOLIZUMAB, A. immunotherapy Medicine. Researchers used URAPP tests to examine […]
